Table of Contents Author Guidelines Submit a Manuscript
Malaria Research and Treatment
Volume 2014, Article ID 263674, 20 pages
http://dx.doi.org/10.1155/2014/263674
Review Article

Does the Use of Dihydroartemisinin-Piperaquine in Treating Patients with Uncomplicated falciparum Malaria Reduce the Risk for Recurrent New falciparum Infection More Than Artemether-Lumefantrine?

1AngloGold Ashanti Hospital, P.O. Box 10, Obuasi, Ghana
2Florence Nightingale School of Nursing and Midwifery, King’s College London, London SE1 8WA, UK

Received 8 February 2014; Revised 4 May 2014; Accepted 18 May 2014; Published 19 June 2014

Academic Editor: Donatella Taramelli

Copyright © 2014 Wisdom Akpaloo and Edward Purssell. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Global Malaria Program: World Malaria Report, World Health Organization, Geneva, Switzerland, 2012, http://www.who.int/malaria/publications/world_malaria_report_2012/wmr2012_full_report.pdf.
  2. United Nations Millennium Project, Investing in Development: A Practical Plan to Achieve the Millennium Development Goals, United Nations Millennium Project, New York, NY, USA, 2005.
  3. C. J. L. Murray, L. C. Rosenfeld, S. S. Lim et al., “Global malaria mortality between 1980 and 2010: a systematic analysis,” The Lancet, vol. 379, no. 9814, pp. 413–431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Schantz-Dunn and N. M. Nour, “Malaria and pregnancy: a global health perspective,” Reviews in Obstetrics and Gynecology, vol. 2, no. 3, pp. 186–192, 2009. View at Google Scholar
  5. World Health Organization, World Malaria Report, World Health Organization, Geneva, Switzerland, 2010, http://www.who.int/malaria/world_malaria_report_2010/worldmalariareport2010.pdf.
  6. United Nations, The Millennium Development Goals Report, United Nations, New York, NY, USA, 2011, http://mdgs.un.org/unsd/mdg/Resources/Static/Products/Progress2011/11-31339%20(E)%20MDG%20Report%202011_Book%20LR.pdf.
  7. M. W. Hetzel, B. Obrist, C. Lengeler et al., “Obstacles to prompt and effective malaria treatment lead to low community-coverage in two rural districts of Tanzania,” BMC Public Health, vol. 8, article 317, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Chuma, T. Abuya, D. Memusi et al., “Reviewing the literature on access to prompt and effective malaria treatment in Kenya: implications for meeting the Abuja targets,” Malaria Journal, vol. 8, no. 1, article 243, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Chuma, V. Okungu, and C. Molyneux, “Barriers to prompt and effective malaria treatment among the poorest population in Kenya,” Malaria Journal, vol. 9, no. 1, article 144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Wongsrichanalai, A. L. Pickard, W. H. Wernsdorfer, and S. R. Meshnick, “Epidemiology of drug-resistant malaria,” Lancet Infectious Diseases, vol. 2, no. 4, pp. 209–218, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. World Health Organization, Antimalarial Drug Combination Therapy: Report of a World Health Organization Technical Consultation, World Health Organization, Geneva, Switzerland, 2001, http://whqlibdoc.who.int/hq/2001/WHO_CDS_RBM_2001.35.pdf.
  12. World Health Organization, Guidelines for the Treatment of Malaria, World Health Organization, Geneva, Switzerland, 2006, http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf.
  13. M. Adjuik, A. Babiker, P. Garner et al., “Artesunate combinations for treatment of malaria: meta-analysis,” The Lancet, vol. 363, no. 9402, pp. 9–17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. R. T. Eastman and D. A. Fidock, “Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria,” Nature Reviews Microbiology, vol. 7, no. 12, pp. 864–874, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Arinaitwe, T. G. Sandison, H. Wanzira et al., “Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children,” Clinical Infectious Diseases, vol. 49, no. 11, pp. 1629–1637, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. R. N. Price, “Potential of artemisinin-based combination therapies to block malaria transmission,” Journal of Infectious Diseases, vol. 207, no. 11, pp. 1627–1629, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Sinclair, B. Zani, S. Donegan, P. Olliaro, and P. Garner, “Artemisinin-based combination therapy for treating uncomplicated malaria,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD007483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Naing, J. W. Mak, K. Aung, and J. Y. R. Wonga, “Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 107, no. 2, pp. 65–73, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Olliaro, L. Pinoges, F. Checchi, M. Vaillant, and J.-P. Guthmann, “Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment,” Tropical Medicine and International Health, vol. 13, no. 1, pp. 83–90, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. Shaukat, E. A. Gilliams, L. J. Kenefic et al., “Clinical manifestations of new versus recrudescent malaria infections following anti-malarial drug treatment,” Malaria Journal, vol. 11, article 207, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” PLoS Medicine, vol. 6, no. 7, Article ID e1000097, 2009. View at Publisher · View at Google Scholar
  22. J. P. T. Higgins and S. Green, Eds., Cochrane Handbook for Systematic Reviews of Interventions, Wiley-Blackwell, Chichester, UK, 2008.
  23. L. Bax, L.-M. Yu, N. Ikeda, and K. G. M. Moons, “A systematic comparison of software dedicated to meta-analysis of causal studies,” BMC Medical Research Methodology, vol. 7, article 40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. D. Simon, Statistical Evidence in Medical Trials: What Do the Data Really Tell Us?Oxford University Press, Oxford, UK, 2006.
  25. G. H. Guyatt, A. D. Oxman, G. E. Vist et al., “GRADE: an emerging consensus on rating quality of evidence and strength of recommendations,” British Medical Journal, vol. 336, no. 7650, pp. 924–926, 2008. View at Google Scholar · View at Scopus
  26. H. Balshem, M. Helfand, H. J. Schünemann et al., “GRADE guidelines: 3. Rating the quality of evidence,” Journal of Clinical Epidemiology, vol. 64, no. 4, pp. 401–406, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Borenstein, L. V. Hedges, J. P. T. Higgins, and H. R. Rothshstein, “A basic introduction to fixed-effect and random-effects models for meta-analysis,” Research Synthesis Methods, vol. 1, no. 2, pp. 97–111, 2010. View at Google Scholar
  28. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, “Measuring inconsistency in meta-analyses,” British Medical Journal, vol. 327, no. 7414, pp. 557–560, 2003. View at Google Scholar · View at Scopus
  29. I. Adam, M. T. Salah, H. G. Eltahir, A. H. Elhassan, K. A. Elmardi, and E. M. Malik, “Dihydroartemisinin-piperaquine versus artemether-lumefantrine, in the treatment of uncomplicated Plasmodium falciparum malaria in central Sudan,” Annals of Tropical Medicine and Parasitology, vol. 104, no. 4, pp. 319–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. M. R. Kamya, A. Yeka, H. Bukirwa et al., “Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial,” PLoS Clinical Trials, vol. 2, no. 5, article e20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. P. F. Mens, P. Sawa, S. M. van Amsterdam et al., “A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya,” Malaria Journal, vol. 7, article 237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. Q. Bassat, M. Mulenga, H. Tinto et al., “Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial,” PLoS ONE, vol. 4, no. 11, Article ID e7871, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Yavo, B. Faye, T. Kuete et al., “Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa,” Malaria Journal, vol. 10, article 198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Sawa, S. A. Shekalaghe, C. J. Drakeley et al., “Malaria transmission after artemether-lumefantrine and dihydroartemisinin- piperaquine: a randomized trial,” Journal of Infectious Diseases, vol. 207, no. 11, pp. 1637–1645, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Yeka, G. Dorsey, M. R. Kamya et al., “Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda,” PLoS ONE, vol. 3, no. 6, Article ID e2390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Nambozi, J.-P. van Geertruyden, S. Hachizovu et al., “Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children,” Malaria Journal, vol. 10, article 50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. W. J. Verret, E. Arinaitwe, H. Wanzira et al., “Effect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malaria,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 6, pp. 2629–2635, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Katrak, A. Gasasira, E. Arinaitwe et al., “Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children,” Malaria Journal, vol. 8, no. 1, article 272, 2009. View at Publisher · View at Google Scholar · View at Scopus